ℹ️
🇬🇧
Search
Search for publications relevant for "Intravesical chemotherapy"
Intravesical chemotherapy
Publication
Class
Person
Publication
Programmes
publication
Intravesical chemotherapy in patients with NMIBC
2022 |
First Faculty of Medicine
publication
Intravesical chemotherapy using heat energy in patiens with urothelial carcinoma of the urinary bladder
2017 |
Second Faculty of Medicine
publication
The efficacy and safety outcomes of lower dose BCG compared to intravesical chemotherapy in non-muscle-invasive bladder cancer: A network meta-analysis
2023 |
Second Faculty of Medicine
publication
Re: Long-term Experience with Radiofrequency-induced Hyperthermia Combined with Intravesical Chemotherapy for Non-muscle Invasive Bladder Cancer
2022 |
Second Faculty of Medicine
publication
New options of intravesical instillation therapy in bladder cancer
2018 |
Second Faculty of Medicine
publication
Prognosis of patients with moderate and high-risk non-muscle-invasive bladder cancer treated with intravesical instillations of mitomycin C during unavailability of BCG vaccine
2016 |
First Faculty of Medicine
publication
ICUD-EAU International Consultation on Bladder Cancer 2012: Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2013 |
Second Faculty of Medicine
publication
Intravesical therapy of urinary bladder tumours
2014 |
First Faculty of Medicine
publication
Long-term Cancer-specific Outcomes of TaG1 Urothelial Carcinoma of the Bladder
2014 |
Second Faculty of Medicine
publication
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-2019 Update
2019 |
Second Faculty of Medicine, First Faculty of Medicine
publication
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 |
Second Faculty of Medicine
publication
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
+1
2011 |
Second Faculty of Medicine
publication
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2017 |
Second Faculty of Medicine, First Faculty of Medicine
publication
Treatment of low-risk non-muscle-invasive bladder cancer
2012 |
Second Faculty of Medicine
publication
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
2022 |
Second Faculty of Medicine, First Faculty of Medicine
publication
Diagnosis and Therapy of Superficial Bladder Cancer
2002 |
First Faculty of Medicine
publication
Diagnosis and Therapy of Superficial Bladder Cancer
2002 |
Faculty of Physical Education and Sport
publication
Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?
2018 |
Second Faculty of Medicine, First Faculty of Medicine
publication
What to do during Bacillus Calmette-Guerin shortage? Valid strategies based on evidence
2018 |
Second Faculty of Medicine
publication
Surgical treatment of urinary bladder cancer
2019 |
First Faculty of Medicine
publication
Prognostic factors of early second transurethral resection of non-muscle invasive bladder cancer - 10 years of experience of a referral center
2022 |
Second Faculty of Medicine
publication
Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group
2022 |
Second Faculty of Medicine
publication
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel
2021 |
Second Faculty of Medicine, First Faculty of Medicine
publication
Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients
+1
2021 |
Second Faculty of Medicine, First Faculty of Medicine
publication
An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting
2020 |
Second Faculty of Medicine